The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
CSF, blood-brain barrier, and brain drug delivery
Abstract
INTRODUCTION: There are 2 misconceptions about the cerebrospinal fluid (CSF), the blood-brain barrier (BBB), and brain drug delivery, which date back to the discovery of a barrier between blood and brain over 100 years ago. Misconception 1 is that drug distribution into CSF is a measure of BBB transport. Misconception 2 is that drug injected into the CSF compartment distributes to the inner parenchyma of brain. AREAS COVERED: Drug distribution into the CSF is a function of drug transport across the choroid plexus, which forms the blood-CSF barrier, and not drug transport across the BBB, which is situated at the microvascular endothelium of brain. Drug injected into CSF undergoes rapid efflux to the blood compartment via bulk flow. Drug penetration into brain parenchyma from the CSF is limited by diffusion and drug concentrations in brain decrease exponentially relative to the CSF concentration. EXPERT OPINION: The barrier between blood and brain was discovered in 1913, when it was believed that the BBB was localized to the choroid plexus, and that nutrient flow from blood passed through the CSF en route to brain. These misconceptions are still widely held, and hinder progress in the development of technology for BBB drug delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, intrathecal drug administration is a typical method for drug delivery into the entire ventricular system without passing through the BBB.134,135”
From The blood–brain barrier: Structure, regulation and drug delivery (2023) · cites this paper as [134]
In the citing paper
“Targeting the large cerebral ventricles (intraventricular route) in the frontal lobe of the brain is an easy surgical task, and is commonly used to deliver drugs to the CNS.”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [86]
Citations
Cites
null (2016) · Philosophy Study · doi:10.17265/2159-5313/2016.09.003 · Cited by 28,317
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,776
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,457
Crone, C. (1963) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1963.tb02652.x · Cited by 1,157
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
Rennels, M. L., Gregory, T. F., Blaumanis, O. R., Fujimoto, K., & Grady, P. A. (1985) · Brain Research · doi:10.1016/0006-8993(85)91383-6 · Cited by 752
de Jong, J. M. B. V. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90083-3 · Cited by 666
Pardridge, W. M., Boado, R. J., & Farrell, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38267-x · Cited by 606
Self-citationRadioimmunotherapy of human tumours
Larson, S. M., Carrasquillo, J. A., Cheung, N. V., & Press, O. W. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3925 · Cited by 540
Research works printed but not linked: 11
- Verrees M, 2004, Am Fam Physician, 70, 1071
- Poplack DG, 1977, Cancer Res, 37, 1982
- Brightman MW, 1993, The blood-brain barrier, 107
- Anderson JM, 2001, News Physiol Sci, 16, 126
- Reiber H, 2003, Restor Neurol Neurosci, 21, 79
- Pardridge WM, 1985, Am J Physiol, 249, E534
- Covell DG, 1985, Am J Physiol, 248, R147
- 10.17265/2159-5313/2016.09.003 · DOI · Paper page
- Morrison PF, 1994, Am J Physiol, 266, R292
- Cserr HF, 1981, Am J Physiol, 240, F319
- Zhang X, 1998, Neurosci, 4, 1225
Cited by
Sorted by citations
Items 201–300 of 511
Targeting the Choroid Plexuses for Protein Drug Delivery
Bryniarski, M. A., Ren, T., Rizvi, A. R., Snyder, A. M., & Morris, M. E. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100963 · Cited by 28
Saleh, M. A. A., & de Lange, E. C. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010095 · Cited by 26
IgNAR antibody: Structural features, diversity and applications
Khalid, Z., Chen, Y., Du, Y., Abbas, M., Ma, H., Naz, Z., Mengist, H. M., Cao, M., & Jin, T. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.01.027 · Cited by 27
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm
Yang, H., George, S. J., Thompson, D., Silverman, H. A., Tsaava, T., Tynan, A., Pavlov, V. A., Chang, E. H., Andersson, U., Brines, M. L., et al. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00483-8 · Cited by 28
Boado, R. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071476 · Cited by 27
Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
Mwema, A., Muccioli, G. G., & Rieux, A. D. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.052 · Cited by 27
Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells
Zorniak, M., Clark, P. A., Umlauf, B. J., Cho, Y. K., Shusta, E. V., & Kuo, J. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-16066-1 · Cited by 26
Recent Update on Pharmacokinetics and Drug Metabolism in CNS-based Drug Discovery
Sanap, S. N., Bisen, A. C., Kedar, A. S., Agrawal, S., & Bhatta, R. S. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230707121415 · Cited by 26
Ying, X., Wang, Y., Xu, H., Li, X., Yan, H., Tang, H., Chen, W., & Li, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19784 · Cited by 25
RNA therapies for CNS diseases
Francesco, V. D., Chua, A. J. K., Huang, D., D’souza, A. A., Yang, A., Bleier, B. S., & Amiji, M. M. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115283 · Cited by 27
Advancements in strategies for overcoming the blood–brain barrier to deliver brain-targeted drugs
Qu, Z., Luo, J., Li, Z., Yang, R., Zhao, J., Chen, X., Yu, S., & Shu, H. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1353003 · Cited by 28
Hawley, Z. C. E., Pardo, I. D. R., Cao, S., Zavodszky, M. I., Casey, F., Ferber, K. L., Luo, Y., Hana, S., Chen, S. K., Doherty, J., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.029 · Cited by 26
Ríos, X., Gómez‐Vallejo, V., Martín, A., Cossío, U., Morcillo, M. Á., Alemi, M., Cardoso, I., Quintana, J. R., Jiménez‐Barbero, J., Cotrina, E. Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50071-w · Cited by 24
Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine
Bakker, C., van der Aart, J., Hart, E. P., Klaassen, E. S., Bergmann, K. R., van Esdonk, M. J., Kay, D. G., & Groeneveld, G. J. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12093 · Cited by 24
Mostovenko, E., Saunders, S., Muldoon, P. P., Bishop, L. M., Campen, M. J., Erdely, A., & Ottens, A. K. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab042 · Cited by 24
Mizuno, T. M., Lew, P. S., & Jhanji, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312668 · Cited by 27
Delbreil, P., Rabanel, J., Banquy, X., & Brambilla, D. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114397 · Cited by 25
Modelling the Human Blood–Brain Barrier in Huntington Disease
Vignone, D., Paz, O. G., Fini, I., Cellucci, A., Auciello, G., Battista, M. R., Gloaguen, I., Fortuni, S., Cariulo, C., Khetarpal, V. K., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147813 · Cited by 25
Yang, Y., Zhang, L., & Yang, X. (2018) · Molecules · doi:10.3390/molecules23010225 · Cited by 24
Tan, L. Y., Cunliffe, G., Hogan, M. P., Yeo, X. Y., Oh, C., Jin, B., Kang, J., Park, J., Kwon, M., Kim, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1380063 · Cited by 23
Deep Tissue Penetration of Bottle-Brush Polymers via Cell Capture Evasion and Fast Diffusion
Rabanel, J., Mirbagheri, M., Olszewski, M., Xie, G., Goas, M. L., Latreille, P., Counil, H., Hervé, V., Silva, R. O., Zaouter, C., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c10554 · Cited by 23
Baringer, S. L., Neely, E. B., Palsa, K., Simpson, I. A., & Connor, J. R. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00345-9 · Cited by 21
Handa, M., Sanap, S. N., Bhatta, R. S., Patil, G. P., Palkhade, R., Singh, D. P., & Shukla, R. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00454 · Cited by 23
Distribution of Monocarboxylate Transporters in Brain and Choroid Plexus Epithelium
Ueno, M., Chiba, Y., Murakami, R., Miyai, Y., Matsumoto, K., Wakamatsu, K., Takebayashi, G., Uemura, N., & Yanase, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082062 · Cited by 25
Schwinghamer, K., & Siahaan, T. J. (2023) · Journal of Nanotheranostics · doi:10.3390/jnt4040020 · Cited by 21
Barker, S. J., Thayer, M. B., Kim, C., Tatarakis, D., Simon, M. J., Dial, R. L., Nilewski, L., Wells, R. C., Zhou, Y., Afetian, M. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.25.538145 · Cited by 21
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier
Lafrance‐Vanasse, J., Sadekar, S., Yang, Y., Yadav, D. B., Meilandt, W. J., Wetzel-Smith, M. K., Cai, H., Crowell, S. R., Nguyen, V., Lee, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59447-1 · Cited by 20
Mészáros, M., Phan, T. H. M., Vigh, J. P., Porkoláb, G., Kocsis, A. E., Páli, E. K., Polgár, T. F., Walter, F. R., Bolognin, S., Schwamborn, J. C., et al. (2023) · Cells · doi:10.3390/cells12030503 · Cited by 21
Shiwaku, H., Katayama, S., Gao, M., Kondo, K., Nakano, Y., Motokawa, Y., Toyoda, S., Yoshida, F., Hori, H., Kubota, T., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.028 · Cited by 20
Ni, J., Chen, C., Wang, S., Liu, X., Tan, L., Li, L., Fan, Y., Hou, Y., Dou, H., & Liang, J. F. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03146-z · Cited by 20
Gao, Y., Zhu, J., & Lu, H. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00873-7 · Cited by 19
MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder
Yao, T.-T., Chen, L., Du, Y., Jiang, Z., & Cheng, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04582-x · Cited by 22
Lei, K., Zhou, L., Dan, M., Yang, F., Jian, T., Xin, J., Yu, Z., & Wang, Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030280 · Cited by 20
Rasmussen, C. L. M., Hede, E., Routhe, L. G., Körbelin, J., Helgudóttir, S. S., Thomsen, L. B., Schwaninger, M., Burkhart, A., & Moos, T. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15621 · Cited by 20
Chinraj, V., & Sureshkumar, R. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.120701 · Cited by 24
Kanojia, N., Thapa, K., Kaur, G., Sharma, A., Puri, V., & Verma, N. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104074 · Cited by 19
Application of Nanomaterials in Neurodegenerative Diseases
Cui, W., Fu, W., Lin, Y., & Zhang, T. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200326093410 · Cited by 20
Vyver, A. J. V. D., Walz, A., Heins, M., Abdolzade‐Bavil, A., Kraft, T. E., Waldhauer, I., & Otteneder, M. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.958543 · Cited by 20
Choroid plexus-derived extracellular vesicles exhibit brain targeting characteristics
Pauwels, M. J., Xie, J., Ceroi, A., Balusu, S., Castelein, J., Wonterghem, E. V., Imschoot, G. V., Ward, A., Menheniott, T. R., Gustafsson, O., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121830 · Cited by 19
Microbial metabolites regulate social novelty via CaMKII neurons in the BNST
Liou, C.-W., Cheng, S., Yao, T.-H., Lai, T.-T., Tsai, Y.-H., Chien, C.-W., Kuo, Y., Chou, S.-H., Hsu, C., & Wu, W. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.029 · Cited by 20
Zhu, Y., Wang, G., Kolluru, C., Gu, Y., Gao, H., Zhang, J., Wang, Y., Wilson, D. L., Zhu, X., Flask, C. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40896-x · Cited by 21
Xiao, Y., Guo, H., Wang, G., Li, J., Zhai, Z., Wang, Z., Wang, W., Zhao, Z., Xia, X., Chen, C., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.039 · Cited by 20
Bergman, J., Svenningsson, A., Liv, P., Bergenheim, T. A., & Burman, J. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00205-4 · Cited by 17
Gene Therapy for Rare Neurological Disorders
Flotte, T. R., & Gessler, D. J. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2543 · Cited by 20
Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis
Wong, J. K., Roselle, A. K., Shue, T. M., Shimshak, S. J. E., Beaty, J. M., Celestin, N., Gao, I., Griffin, R., Cudkowicz, M., & Sadiq, S. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac207 · Cited by 17
Bell, K. S., & O’Shaughnessy, K. L. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.1000212 · Cited by 18
Ding, L., You, H.-J., Hu, G.-J., Yao, R., Xie, A., & Li, X.-Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.945356 · Cited by 18
Bai, C., Zhou, X., Yu, L., Wu, A., Yang, L., Chen, J., Tang, X., Zou, W., Wu, J., & Zhu, L. (2023) · Pharmaceuticals · doi:10.3390/ph16020178 · Cited by 17
Precision Medicine in Lymphoma by Innovative Instrumental Platforms
Paolo, A. D., Arrigoni, E., Luci, G., Cucchiara, F., Danesi, R., & Galimberti, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01417 · Cited by 18
Sideromenos, S., Lindtner, C., Zambon, A., Horváth, O., Berger, A., & Pollak, D. D. (2020) · Cells · doi:10.3390/cells9041048 · Cited by 17
Roda, A. R., Montoliu‐Gaya, L., Serra-Mir, G., & Villegas, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186630 · Cited by 17
Dauba, A., Goulas, J., Colin, L., Jourdain, L., Larrat, B., Gennisson, J., Certon, D., & Novell, A. (2020) · The Journal of the Acoustical Society of America · doi:10.1121/10.0002096 · Cited by 16
Transporters, Ion Channels, and Junctional Proteins in Choroid Plexus Epithelial Cells
Ueno, M., Chiba, Y., Murakami, R., Miyai, Y., Matsumoto, K., Wakamatsu, K., Nakagawa, T., Takebayashi, G., Uemura, N., Yanase, K., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12040708 · Cited by 16
Nonnenbroich, L. F., Bouchal, S. M., Millesi, E., Rechberger, J. S., Khatua, S., & Daniels, D. J. (2024) · Cells · doi:10.3390/cells13131122 · Cited by 18
Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine
Blomqvist, K. J., Skogster, M. O. B., Kurkela, M. J., Rosenholm, M., Ahlström, F. H. G., Airavaara, M., Backman, J. T., Rauhala, P. V., Kalso, E. A., & Lilius, T. O. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.022 · Cited by 17
Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier
Boado, R. J. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00204d · Cited by 19
Molecular fMRI of neurochemical signaling
Wei, H., Frey, A. M., & Jasanoff, A. (2021) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109372 · Cited by 15
Current Approaches to Monitor Macromolecules Directly from the Cerebral Interstitial Fluid
Custers, M., Nestor, L., Bundel, D. D., Eeckhaut, A. V., & Smolders, I. J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051051 · Cited by 15
Chang, K. W., Hong, S. W., Chang, W. S., Jung, H. H., & Chang, J. W. (2023) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2022.0236 · Cited by 15
Zaghmi, A., Drouin‐Ouellet, J., Brambilla, D., & Gauthier, M. A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120461 · Cited by 17
Chang, H.-Y., Wu, S., Chowdhury, E. A., & Shah, D. K. (2022) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-021-09800-w · Cited by 16
Chang, H.-Y., Wu, S., Li, Y., Guo, L., Li, Y., & Shah, D. K. (2022) · The AAPS Journal · doi:10.1208/s12248-022-00701-5 · Cited by 16
A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology
Vogelbaum, M. A., Li, G., Heimberger, A. B., Lang, F. F., Fueyo-Margareto, J., Gomez‐Manzano, C., & Sanai, N. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_349175 · Cited by 15
The Blood brain-barrier and its role in Alzheimer’s disease
Storck, S. E., & Pietrzik, C. U. (2018) · e-Neuroforum · doi:10.1515/nf-2018-a014 · Cited by 16
Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances
Pellerino, A., Internò, V., Muscolino, E., Mo, F., Bruno, F., Pronello, E., Franchino, F., Soffietti, R., & Rudà, R. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.80 · Cited by 15
Fernández, M., Nigro, M., Travagli, A., Pasquini, S., Vincenzi, F., Varani, K., Borea, P. A., Merighi, S., & Gessi, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102441 · Cited by 16
Nose to Brain Drug Delivery: A Recent Update
Chatterjee, B. (2018) · Journal of Formulation Science & Bioavailability · doi:10.4172/2577-0543.1000105 · Cited by 14
Chimeric Small Antibody Fragments as Strategy to Deliver Therapeutic Payloads
Aguiar, S. I., Dias, J., Manuel, A. M., Russo, R. L., Góis, P. M. P., Aires‐da‐Silva, F., & Gonçalves, J. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.03.002 · Cited by 14
Chou, S.-W., Mortberg, M. A., Marlen, K., Ojala, D. S., Parman, T., Howard, M., DeSouza-Lenz, K., Lian, Y., Mehrabian, M., Tiffany, M. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.05.636713 · Cited by 14
Li, J., Wickramasinghe, C. D., Jiang, J., Wu, A., Jiang, Y., Tovmasyan, A. G., Kim, S., & Sanai, N. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3505 · Cited by 16
Zhang, Y.-B., Liu, M., Wang, Y., Hu, D., Wu, S., Zhao, B., Zhou, B., & Yang, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177958 · Cited by 14
Miniaturized neural implants for localized and controllable drug delivery in the brain
Zhao, X., Deng, M., Wang, J., Liu, B., Dong, Y., & Li, Z. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00728f · Cited by 14
Cell-Penetrating Peptides-Mediated Therapeutic Agents Delivery into the Central Nervous System
Wei, Y., Bao, H., Wang, L., Cao, Y., Liu, Z., Zhu, X., Chen, T., Wu, A., & Li, J. (2024) · ACS Materials Letters · doi:10.1021/acsmaterialslett.4c00397 · Cited by 13
Khan, S., Bano, N., Ahamad, S., Dar, N. J., Nazir, A., & Bhat, S. A. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216206 · Cited by 14
Ma, J., Huang, L., & Han, C. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241289648 · Cited by 13
Nadim, N., Khan, A. A., Khan, S. M., Parveen, R., & Ali, J. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103341 · Cited by 13
Schartmann, E., Schemmert, S., Ziehm, T., Leithold, L. H. E., Jiang, N., Tusche, M., Shah, N. J., Langen, K., Kutzsche, J., Willbold, D., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.12.005 · Cited by 13
Ljubimov, V. A., Ramesh, A., Davani, S., Danielpour, M., Breunig, J. J., & Black, K. L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114033 · Cited by 13
Ma, J., Wang, B., Wei, X., Tian, M., Bao, X., Zhang, Y., Qi, H., Zhang, Y., & Hu, M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16039 · Cited by 12
Delayed Gadolinium Leakage in Ocular Structures
Galmiche, C., Moal, B., Marnat, G., Sagnier, S., Schweitzer, C., Dousset, V., Sibon, I., & Tourdias, T. (2021) · Investigative Radiology · doi:10.1097/rli.0000000000000757 · Cited by 12
Kumar, N., Khurana, B., & Arora, D. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2285506 · Cited by 12
Jiang, F., Ren, J., Gao, Y., Wang, J., Zhao, Y., & Dai, F. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.11.024 · Cited by 11
Twofold Saddle-Point Formulation of Biot Poroelasticity with Stress-Dependent Diffusion
Gómez-Vargas, B., Mardal, K., Ruíz-Baier, R., & Vinje, V. (2023) · SIAM Journal on Numerical Analysis · doi:10.1137/21m1449695 · Cited by 14
Kusaka, S., Morizane, Y., Tokumaru, Y., Tamaki, S., Maemunah, I. R., Akiyama, Y., Sato, F., & Murata, I. (2022) · Biology · doi:10.3390/biology11030397 · Cited by 11
Kusaka, S., Morizane, Y., Tokumaru, Y., Tamaki, S., Maemunah, I. R., Akiyama, Y., Sato, F., & Murata, I. (2022) · Research in Veterinary Science · doi:10.1016/j.rvsc.2022.04.008 · Cited by 11
Glymphatic System in Ocular Diseases: Evaluation of MRI Findings
Manava, P., Eckrich, C., Luciani, F., Schmidbauer, J. M., Lell, M., & Detmar, K. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7552 · Cited by 12
Long non-coding RNAs as biomarkers and therapeutic targets for ischemic stroke
Суфианова, Г. З., Shumadalova, A. V., Wenhao, Y., & Фанилевич, Г. И. (2022) · Non-coding RNA Research · doi:10.1016/j.ncrna.2022.09.004 · Cited by 11
Polymer nanocarriers for targeted local delivery of agents in treating brain tumors
Josowitz, A. D., Bindra, R. S., & Saltzman, W. M. (2022) · Nanotechnology · doi:10.1088/1361-6528/ac9683 · Cited by 12
Application of Nanotechnology-Based Products in Stroke
Wang, C., Sun, J., Chen, Q., Chen, J., Wan, H., Ni, Q., Yuan, H., Wu, J., Wang, Y., & Sun, B. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00804 · Cited by 11
A 3D brain unit model to further improve prediction of local drug distribution within the brain
Vendel, E., Rottschäfer, V., & de Lange, E. C. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238397 · Cited by 11
Quantitative and qualitative analysis of direct nose-to-brain drug delivery
Belgamwar, V. S., Bhoyar, V. T., Trivedi, S., & Pardeshi, C. V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00027-8 · Cited by 11
Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics
Chan, M., Huang, W., Satpathy, A., Su, T., Hsiao, M., & Liu, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020456 · Cited by 11
Signaling pathways driving multiple sclerosis: From mechanisms to natural‑product interventions
El‐Dessouki, A. M., Shalaby, H. N., Khalaf, S. S., Abd‐Elmawla, M. A., Ghaiad, H. R., Mageed, S. S. A., El‐Shiekh, R. A., Ahmed, S., & Khalifa, H. O. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119543 · Cited by 10
Giordano, G., Griguolo, G., Landriscina, M., Meattini, I., Carbone, F., Leone, A., Re, M. D., Fogli, S., Danesi, R., Colamaria, A., et al. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104185 · Cited by 12
Li, J., Wu, A., & Kim, S. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3062 · Cited by 10
Focused ultrasound therapy as a strategy for improving glioma treatment
Young, J. S., Semonche, A. M., Morshed, R. A., Al-Adli, N. N., Haddad, A. F., Gerritsen, J. K. W., Saggi, S. S., Narsinh, K. H., de Groot, J., & Aghi, M. K. (2025) · Journal of neurosurgery · doi:10.3171/2024.9.jns24721 · Cited by 11
Phatale, V., Khairnar, P., Shukla, S., Puri, N., Sahane, P., & Srivastava, S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126077 · Cited by 11
Hampering Brain Tumor Proliferation and Migration Using Peptide Nanofiber:si PLK1 / MMP2 Complexes
Mazza, M., Ahmad, H., Hadjidemetriou, M., Agliardi, G., Pathmanaban, O. N., King, A. T., Bigger, B., Vranic, S., & Kostarelos, K. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0298 · Cited by 10
Lee, N. K., Kim, H., Chang, J. W., Jang, H., Kim, H., Yang, J., Kim, J., Son, J. P., & Na, D. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155524 · Cited by 10
Biomimetic Drug Delivery Systems Oriented by Biological Function in Tumor Targeting
Wang, R., & Sha, X. (2021) · Current Drug Targets · doi:10.2174/1389450122666210114095859 · Cited by 10
Metadata
- Authors
- Pardridge, W. M.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Pardridge, William M.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2016-04-11
- Volume
- 13
- Issue
- 7
- Pages
- 963-975
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2314371091
- Cited by
- 508
- References
- 88
- Citations by year
- 2026: 33 · 2025: 45 · 2024: 63 · 2023: 63 · 2022: 84 · 2021: 64 · 2020: 58 · 2019: 37 · 2018: 29 · 2017: 27 · 2016: 4
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Delivery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- cerebrospinal fluid, blood-brain barrier, brain drug delivery, choroid plexus, blood-CSF barrier, drug transport, bulk flow
- MeSH terms
- Animals, Biological Transport, Blood-Brain Barrier, Brain, Choroid Plexus, Humans, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review